Phase 3 trial of once-weekly canvuparatide remains on track to initiate in Q3 2026 following recently completed, successful End-of-Phase 2 ...

TOKYO, March 13, 2026 /PRNewswire/ -- PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc. today announced that they have entered into a drug discovery collaboration agreement (the "Collaboration") ...

Appointment brings deep life sciences, clinical, & global market expertise to DiaGen as it scales its AI-driven ...

Marsha Ettinghoff died from stomach paralysis, a condition where food passes through the stomach slower than it should.

Food allergies are serious and, for some, potentially deadly. And yet, despite decades of research into allergies and what causes them, very little is known about why the vast majority of people are ...

Stimuli-responsive nanomaterials enhance targeted drug delivery, improving treatment precision for inflammatory diseases through innovative design strategies.

Teratophiliacs were once a niche group that bonded over their sexual attraction to monsters in obscure forums. Now—as online communities proliferate and genres like romantasy grow—monster porn is goin ...

Anfisa Skin founder Aly Korchemniy shares her highly coveted beauty routine.

The company received $441,437 from the foundation to miniaturize its molecular point-of-care test for HIV viral load.

Globally, peptide therapeutics have been gaining attention in research as well as clinical practice. Studies show that more than 80 peptide-based drugs have already been approved worldwide, while over ...

The dupe-culture darling just raised $500 million. I ask its first head of brand and narrative how she's positioning the brand for hyper growth.